Literature DB >> 5844954

Effect of penicillamine on serum iron.

J M Walshe, V Patston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5844954      PMCID: PMC2019492          DOI: 10.1136/adc.40.214.651

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  9 in total

1.  PYRIDOXINE DEFICIENCY IN THE RAT PRODUCED BY D-PENICILLAMINE.

Authors:  A M ASATOOR
Journal:  Nature       Date:  1964-09-26       Impact factor: 49.962

2.  PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION.

Authors:  I STERNLIEB; I H SCHEINBERG
Journal:  JAMA       Date:  1964-09-07       Impact factor: 56.272

3.  NEPHROTIC SYNDROME ASSOCIATED WITH PENICILLAMINE THERAPY OF WILSON'S DISEASE.

Authors:  D A ADAMS; R GOLDMAN; M H MAXWELL; H LATTA
Journal:  Am J Med       Date:  1964-02       Impact factor: 4.965

4.  HEPATO-LENTICULAR DEGENERATION (WILSON'S DISEASE) TREATED BY PENICILLAMINE.

Authors:  J RICHMOND; V M ROSENOER; S L TOMPSETT; I DRAPER; J A SIMPSON
Journal:  Brain       Date:  1964-12       Impact factor: 13.501

5.  THE ANTIPYRIDOXINE EFFECT OF PENICILLAMINE IN MAN.

Authors:  I A JAFFE; K ALTMAN; P MERRYMAN
Journal:  J Clin Invest       Date:  1964-10       Impact factor: 14.808

6.  Treatment of Wilson's disease with penicillamine.

Authors:  J M WALSHE
Journal:  Lancet       Date:  1960-01-23       Impact factor: 79.321

7.  The determination of iron in blood plasma or serum.

Authors:  W N RAMSAY
Journal:  Clin Chim Acta       Date:  1957-06       Impact factor: 3.786

8.  An increased vitamin B6 requirement in the rat on a diet containing L-penicillamine.

Authors:  V DU VIGNEAUD; E J KUCHINSKAS
Journal:  Arch Biochem Biophys       Date:  1957-01       Impact factor: 4.013

9.  Treatment of Wilson's disease (hepatolenticular degeneration) with DL-penicillamine.

Authors:  N P GOLDSTEIN; R V RANDALL; J B GROSS; J W ROSEVEAR; W F McGUCKIN
Journal:  Neurology       Date:  1962-04       Impact factor: 9.910

  9 in total
  3 in total

1.  New Agent in the Treatment of Cystinuria: N-acetyl-D-penicillamine.

Authors:  G S Stokes; J T Potts; M Lotz; F C Bartter
Journal:  Br Med J       Date:  1968-02-03

2.  Serum ferritin in juvenile chronic polyarthritis.

Authors:  A W Craft; E J Eastham; J I Bell; K Brigham
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

Review 3.  Red cell aplasia following prolonged D-penicillamine therapy.

Authors:  J L Gollan; S Hussein; A V Hoffbrand; S Sherlock
Journal:  J Clin Pathol       Date:  1976-02       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.